Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 231

1.
2.
3.

Neutropenia and anaemia due to carbimazole-dependent antibodies.

Bux J, Ernst-Schlegel M, Rothe B, Panzer C.

Br J Haematol. 2000 Apr;109(1):243-7.

PMID:
10848805
4.

Ceftriaxone causes drug-induced immune thrombocytopenia and hemolytic anemia: characterization of targets on platelets and red blood cells.

Grossjohann B, Eichler P, Greinacher A, Santoso S, Kroll H.

Transfusion. 2004 Jul;44(7):1033-40.

PMID:
15225244
5.

Glycoprotein IIb/IIIa complex is the target in mirtazapine-induced immune thrombocytopenia.

Liu X, Sahud MA.

Blood Cells Mol Dis. 2003 May-Jun;30(3):241-5.

PMID:
12737939
6.

Glycoprotein V-specific platelet-associated antibodies in thrombocytopenic patients.

Joutsi-Korhonen L, Javela K, Hormila P, Kekomäki R.

Clin Lab Haematol. 2001 Oct;23(5):307-12.

PMID:
11703413
7.
8.
9.

Association of autoantibodies against platelet glycoproteins Ib/IX and IIb/IIIa, and platelet-reactive anti-HIV antibodies in thrombocytopenic narcotic addicts.

Gonzalez-Conejero R, Rivera J, Rosillo MC, Cano A, Rodriguez T, Vicente V.

Br J Haematol. 1996 May;93(2):464-71.

PMID:
8639450
10.

Glycoprotein Ib/IX complex is the target in rifampicin-induced immune thrombocytopenia.

Pereira J, Hidalgo P, Ocqueteau M, Blacutt M, Marchesse M, Nien Y, Letelier L, Mezzano D.

Br J Haematol. 2000 Sep;110(4):907-10.

PMID:
11054081
11.

Platelet autoantibodies (IgG, IgM, IgA) against glycoproteins IIb/IIIa and Ib/IX in patients with thrombocytopenia.

Kiefel V, Freitag E, Kroll H, Santoso S, Mueller-Eckhardt C.

Ann Hematol. 1996 Apr;72(4):280-5.

PMID:
8624385
12.

Anti-platelet antibodies in patients with systemic lupus erythematosus and the primary antiphospholipid antibody syndrome: their relationship with the observed thrombocytopenia.

Macchi L, Rispal P, Clofent-Sanchez G, Pellegrin JL, Nurden P, Leng B, Nurden AT.

Br J Haematol. 1997 Aug;98(2):336-41.

PMID:
9266930
14.

Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediated.

Billheimer JT, Dicker IB, Wynn R, Bradley JD, Cromley DA, Godonis HE, Grimminger LC, He B, Kieras CJ, Pedicord DL, Spitz SM, Thomas BE, Zolotarjova NI, Gorko MA, Hollis GF, Daly RN, Stern AM, Seiffert D.

Blood. 2002 May 15;99(10):3540-6.

15.

Drug-induced and drug-dependent immune thrombocytopenias.

Greinacher A, Eichler P, Lubenow N, Kiefel V.

Rev Clin Exp Hematol. 2001 Sep;5(3):166-200; discussion 311-2. Review.

PMID:
11703814
16.

Detection of drug-dependent, platelet-reactive antibodies by antigen-capture ELISA and flow cytometry.

Visentin GP, Wolfmeyer K, Newman PJ, Aster RH.

Transfusion. 1990 Oct;30(8):694-700.

PMID:
2219255
17.

Characterization of multiple quinine-dependent antibodies in a patient with episodic hemolytic uremic syndrome and immune agranulocytosis.

Stroncek DF, Vercellotti GM, Hammerschmidt DE, Christie DJ, Shankar RA, Jacob HS.

Blood. 1992 Jul 1;80(1):241-8.

18.

Rosiglitazone-induced immune thrombocytopenia.

Liu X, Huang T, Sahud MA.

Platelets. 2006 May;17(3):143-8.

PMID:
16702039
20.

Target platelet antigens of autoantibodies in patients with primary biliary cirrhosis.

Feistauer SM, Penner E, Mayr WR, Panzer S.

Hepatology. 1997 Jun;25(6):1343-5.

PMID:
9185750
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk